at the Harvard Affiliated Hospitals
Clinical and scientific studies to understand and discover new treatments for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS), Long COVID, and related Multisystem, Chronic Complex Diseases (msCCD).
Established in 2018, this research initiative is based at Harvard affiliated hospitals, including Massachusetts General Hospital (MGH), Brigham and Women’s Hospital (BWH), and Beth Israel Deaconess Medical Center (BIDMC).
Including the faculty of the Harvard affiliated hospitals, critical collaborations are represented from Stanford University, Cornell University, University of Birmingham, University of Nottingham, Uppsala University and Pacific Northwest National Laboratory.
This collaborative research center was launched by Ronald G. Tompkins, MD, ScD, and Wenzhong Xiao, PhD.
In early 2022, David Systrom, MD joined Wenzhong Xiao as a Co-Director after Ronald G. Tompkins’ sudden passing.
This research collaboration seeks to understand and discover new treatments for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS), Long COVID, and related Multisystem, Chronic Complex Diseases (msCCD).
the role of neuroinflammation in ME/CFS
the infrastructure to begin treatment trials and form a center of excellence for ME/CFS
Remembering Ron A Champion of ME/CFS Research, and Friend to All In Dr. Tompkins’ role as OMF’s Chief Medical Officer, he facilitated communication between the
New research publication authored by Team OMF! Breaking news! A new research publication authored by Dr. Ronald Davis, Dr. Wenzhong Xiao, OMF’s CEO & Founder,
Dr. David Systrom, pulmonary physician at Brigham & Women’s Hospital and investigator at Massachusetts General Hospital in association with the Harvard ME / CFS Collaboration, has recently
This project aims to explore the biological changes that occur in the muscles during Post-exertional Malaise (PEM).
The study expands on a previously-awarded proposal to thoroughly explore the underlying pathophysiology of post exertional malaise (PEM), the hallmark symptom of ME/CFS.
We intend to examine multiple sleep studies that have been conducted in the past two years and performed at the MGH Neurology Sleep Medicine Laboratory in well characterized patients with ME/CFS.
This study aims to evaluate different explanations of preload failure in ME/CFS patients.
This clinical trial will test the exercise response to Mestinon in people with ME/CFS.
Researchers are developing a tool to help clinicians more efficiently define the character and priorities of a patient’s current symptoms of ME/CFS, Post-Treatment Lyme Disease, or Fibromyalgia.
This project aims to understand the origin of postural orthostatic tachycardia syndrome (POTS).
Massachusetts General Hospital
In Memoriam – Ronald Tompkins, MD, ScD
Wenzhong Xiao, PhD
Donna Felsenstein, MD
Amel Karaa, MD
Andrew Alexander, MBA
Peng Li, PhD
Karen Buch, MD
Brigham & Womens Hospital
David Systrom, MD
Anthony Komaroff, MD
BI Deaconess Medical Center
Janet Mullington, PhD
Boston University
Lewis Kazis, ScD
Mary Slavin, PhD
Pengsheng Ni, PhD
Bill Rogers, PhD
Pacific Northwest National Laboratory
Richard Smith, PhD
John Jacob, PhD
Wei-Jun Qian, PhD
Chiari Neurosurgical Center
Paolo Bologenese, MD
Ilene Ruhoy, MD
Center For Healing Neurology
David Kaufman, MD
University of Nottingham, UK
Philip Atherton, PhD
Paul Greenhaff, PhD
Daniel Wilkinson, PhD
Mathew Piasecki, PhD
University of Birmingham, UK
Janet Lord, PhD
Cornell University
Maureen Hanson, PhD
Open Medicine Foundation
Linda Tannenbaum
Chris Armstrong, PhD
Stanford University
Ronald Davis, PhD
Uppsala University, Sweden
Jonas Bergquist, MD, PhD
Please help us expand our research efforts across the globe. Every donation brings us closer to a fully-funded research effort and the answers we all seek.
Open Medicine Foundation®
29302 Laro Drive, Agoura Hills, CA 91301 USA
Phone: 650-242-8669
Copyright © 2023 Open Medicine Foundation. All Rights Reserved.
What are the advantages of giving from your Donor Advised Fund (DAF)?
How do I make a donation through my DAF?
Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.
Still can’t find your fund?
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).Gifting of Stock
Broker: Schwab
DTC #: 0164
Account #: 47083887
Account Registered as:
Open Medicine Foundation
29302 Laro Drive
Agoura Hills, CA 91301
Please speak to your personal tax advisor and then call OMF at 650-242-8669 to notify us of your donation or with any questions.